Sanz RL - Search Results

1

Vitamin D-RAAS Connection: An Integrative Standpoint into Cardiovascular and Neuroinflammatory Disorders.

Giménez VMM, Sanz RL, Marón FJM, Ferder L, Manucha W. Giménez VMM, et al. Among authors: sanz rl. Curr Protein Pept Sci. 2020;21(10):948-954. doi: 10.2174/1389203721666200606220719. Curr Protein Pept Sci. 2020. PMID: 32504501 Review.

2

Vitamin D-mitochondria cross-talk could modulate the signaling pathway involved in hypertension development: a translational integrative overview.

Sanz R, Mazzei L, Santino N, Ingrasia M, Manucha W. Sanz R, et al. Clin Investig Arterioscler. 2020 Jul-Aug;32(4):144-155. doi: 10.1016/j.arteri.2020.02.002. Epub 2020 May 23. Clin Investig Arterioscler. 2020. PMID: 32456803 Review. English, Spanish.

3

Cannabinoids as Potential Molecules for Addiction Disorders.

Martín Giménez VM, Mazzei L, Sanz R, Manucha W. Martín Giménez VM, et al. Curr Protein Pept Sci. 2022;23(3):152-157. doi: 10.2174/1389203723666220510121031. Curr Protein Pept Sci. 2022. PMID: 35538819 Review.

4

Alterations on a key nephrogenic/cardiogenic gene expression linked to hypertension development.

Mazzei L, Sanz R, Manucha W. Mazzei L, et al. Clin Investig Arterioscler. 2020 Mar-Apr;32(2):70-78. doi: 10.1016/j.arteri.2019.06.001. Epub 2019 Aug 28. Clin Investig Arterioscler. 2020. PMID: 31472952 Review. English, Spanish.

5

Implications of the transcription factor WT1 linked to the pathologic cardiac remodeling post-myocardial infarction.

Sanz RL, Mazzei L, Manucha W. Sanz RL, et al. Clin Investig Arterioscler. 2019 May-Jun;31(3):121-127. doi: 10.1016/j.arteri.2018.08.003. Epub 2018 Oct 3. Clin Investig Arterioscler. 2019. PMID: 30292449 Review. English, Spanish.

6

Anandamide-nanoformulation obtained by electrospraying for cardiovascular therapy.

Martín Giménez VM, Díaz-Rodríguez P, Sanz RL, Vivero-Lopez M, Concheiro A, Diez E, Prado N, Enrique Kassuha D, Alvarez-Lorenzo C, Manucha W. Martín Giménez VM, et al. Among authors: sanz rl. Int J Pharm. 2019 Jul 20;566:1-10. doi: 10.1016/j.ijpharm.2019.05.047. Epub 2019 May 18. Int J Pharm. 2019. PMID: 31112795

7

Kidney-Protector Lipidic Cilastatin Derivatives as Structure-Directing Agents for the Synthesis of Mesoporous Silica Nanoparticles for Drug Delivery.

Martinez-Erro S, Navas F, Romaní-Cubells E, Fernández-García P, Morales V, Sanz R, García-Muñoz RA. Martinez-Erro S, et al. Int J Mol Sci. 2021 Jul 26;22(15):7968. doi: 10.3390/ijms22157968. Int J Mol Sci. 2021. PMID: 34360733 Free PMC article.

8

L-Dopa release from mesoporous silica nanoparticles engineered through the concept of drug-structure-directing agents for Parkinson's disease.

Morales V, McConnell J, Pérez-Garnes M, Almendro N, Sanz R, García-Muñoz RA. Morales V, et al. J Mater Chem B. 2021 May 26;9(20):4178-4189. doi: 10.1039/d1tb00481f. J Mater Chem B. 2021. PMID: 33989370

9

Cytostatic and Cytotoxic Effects of Hollow-Shell Mesoporous Silica Nanoparticles Containing Magnetic Iron Oxide.

Pérez-Garnes M, Morales V, Sanz R, García-Muñoz RA. Pérez-Garnes M, et al. Nanomaterials (Basel). 2021 Sep 21;11(9):2455. doi: 10.3390/nano11092455. Nanomaterials (Basel). 2021. PMID: 34578771 Free PMC article.

10

Engineering hollow mesoporous silica nanoparticles to increase cytotoxicity.

Pérez-Garnes M, Gutiérrez-Salmerón M, Morales V, Chocarro-Calvo A, Sanz R, García-Jiménez C, García-Muñoz RA. Pérez-Garnes M, et al. Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110935. doi: 10.1016/j.msec.2020.110935. Epub 2020 Apr 8. Mater Sci Eng C Mater Biol Appl. 2020. PMID: 32409082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters